Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
Symptom severity and mindreading in narcissistic personality disorder.
Bilotta E, Carcione A, Fera T, Moroni F, Nicolò G, Pedone R, Pellecchia G, Semerari A, Colle L. Bilotta E, et al. Among authors: fera t. PLoS One. 2018 Aug 15;13(8):e0201216. doi: 10.1371/journal.pone.0201216. eCollection 2018. PLoS One. 2018. PMID: 30110368 Free PMC article.
Clinical support role for a pharmacy technician within a primary care resource center.
Fera T, Kanel KT, Bolinger ML, Fink AE, Iheasirim S. Fera T, et al. Am J Health Syst Pharm. 2018 Feb 1;75(3):139-144. doi: 10.2146/ajhp160646. Am J Health Syst Pharm. 2018. PMID: 29371195
Avoidant personality disorder and social phobia: Does mindreading make the difference?
Pellecchia G, Moroni F, Colle L, Semerari A, Carcione A, Fera T, Fiore D, Nicolò G, Pedone R, Procacci M. Pellecchia G, et al. Among authors: fera t. Compr Psychiatry. 2018 Jan;80:163-169. doi: 10.1016/j.comppsych.2017.09.011. Epub 2017 Sep 28. Compr Psychiatry. 2018. PMID: 29096207
ASHP Guidelines on Preventing Diversion of Controlled Substances.
Brummond PW, Chen DF, Churchill WW, Clark JS, Dillon KR, Dumitru D, Eschenbacher L, Fera T, Fortier CR, Gullickson KK, Jurakovich K, Kent S, Keonavong J, Marchese C, Meyer T, Murdaugh LB, Ogden RK Jr, O'Neal BC, Rough S, Saenz R, Smith JS. Brummond PW, et al. Among authors: fera t. Am J Health Syst Pharm. 2017 Mar 1;74(5):325-348. doi: 10.2146/ajhp160919. Epub 2017 Jan 4. Am J Health Syst Pharm. 2017. PMID: 28052859 Review. No abstract available.
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF; FLAME Investigators. Wedzicha JA, et al. N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15. N Engl J Med. 2016. PMID: 27181606 Free article. Clinical Trial.
Role of a care transition pharmacist in a primary care resource center.
Fera T, Anderson C, Kanel KT, Ramusivich DL. Fera T, et al. Am J Health Syst Pharm. 2014 Sep 15;71(18):1585-90. doi: 10.2146/ajhp130684. Am J Health Syst Pharm. 2014. PMID: 25174019
Tiotropium Respimat inhaler and the risk of death in COPD.
Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators. Wise RA, et al. N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30. N Engl J Med. 2013. PMID: 23992515 Free article. Clinical Trial.
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.
Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ; M2-124 and M2-125 study groups. Calverley PM, et al. Lancet. 2009 Aug 29;374(9691):685-94. doi: 10.1016/S0140-6736(09)61255-1. Lancet. 2009. PMID: 19716960 Clinical Trial.
Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization.
Bahadori K, FitzGerald JM, Levy RD, Fera T, Swiston J. Bahadori K, et al. Among authors: fera t. Can Respir J. 2009 Jul-Aug;16(4):e43-9. doi: 10.1155/2009/179263. Can Respir J. 2009. PMID: 19707601 Free PMC article.
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page